| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5583899 | Seminars in Arthritis and Rheumatism | 2017 | 7 Pages |
Abstract
We present three cases, one with exceptionally severe disease, which demonstrated excellent clinical response to Abatacept. Abatacept is a promising option for the treatment of severe or resistant morphea, especially in those with deep tissue involvement.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Fahd MMedSc, MRCPI, Shakeel MRCPI, Philip FFRRCSI, FFSEM, Ahmad MD, MRCPI, Mary Brady, Siobhan Morrissey, Joseph FRCPI, Alexander Duncan FRCPI,